No Trade-Offs on Access to Medicines
Els Torreele
February 7, 2012
 BLOG  
As India and the EU negotiate a Free Trade Agreement, it will be critical for India to resist measures that favor the business interests of pharmaceutical companies over the lives of millions of people in developing countries who depend on India's supply of cheap generic medicines.

Africa Should Be Wary of U.S. Propaganda on Intellectual Property
Brett Davidson
February 3, 2012
 BLOG  
The United States is telling African leaders that adopting stringent intellectual property policies will promote African growth through innovation. In reality, Africa has far more to lose from stricter intellectual property regulation, especially when it comes to access to generic medicines and educational resources.

Why We Shouldn't Rely on Patents to Encourage Medical Innovation
Paul Silva
January 23, 2012
 BLOG  
In an op-ed in the Wall Street Journal, Els Torreele of the Open Society Foundations argues against proposals to extend patents on pharmaceuticals, stating that such a move would solidify a broken innovation model that primarily serves the financial interest of the pharmaceutical industry at the expense of patients worldwide.

"I'm the Evidence": Video Advocacy to Prevent Drug Overdose Deaths
Roxanne Saucier
August 31, 2011
 BLOG    VIDEO  
Access to naloxone, an antidote to opiate overdose, is not only saving lives around the world but also giving drug users hope for a second chance.